News | Radiology Business | October 02, 2019

‘No Consensus’ for Academic Second Opinions on Outside Imaging Studies

There is no consensus among academic radiologists regarding how to handle second-opinion consultations on outside studies, says AJR article

raph shows responses of members of Society of Chairs of Academic Radiology Departments to question “Do you add all OSS images to your PACS?”

Graph shows responses of members of Society of Chairs of Academic Radiology Departments to question “Do you add all OSS images to your PACS?”. OSS = outside studies.

According to an ahead-of-print article published in the January issue of the American Journal of Roentgenology (AJR), there is no consensus among academic radiologists regarding how to handle second-opinion consultations on outside studies (OSS).

Analyzing completed surveys from 91 members of the Society of Chairs of Academic Radiology Departments (SCARD), lead investigators Parisa Khoshpouri and Pegah Khoshpouri found that 70 respondents (76.9 percent) added OSS to their institutional PACS, and 34 (37.4 percent) required formal internal reports on all OSS.

In contrast, 74 (81.3 percent) allowed at least some OSS into their PACS, without requiring an internal report.

“Many respondents interpreted outside studies only if specifically requested,” Khoshpouri and Khoshpouri noted.

A majority (67/91 [73.6 percent]) billed insurers — though not patients (61/91 [67 percent]) — for the second-opinion consultations. Meanwhile, 15 (16.5 percent) preferred repeating studies, rather than including OSS in the PACS.

With minimal exceptions, the results from the 91 of 160 invited (56.9 percent) SCARD respondents paralleled the results from the 35 of 106 invited (33 percent) Association of Administration in Academic Radiology members.

“Developing a best practices statement that addresses patient care, medicolegal implications for radiology departments and referring physicians, financial implications, and quality and safety precepts would be a useful endeavor for organized radiology,” stated Khoshpouri and Khoshpouri.

“In so doing,” they continued, “radiologists may gain more clarity from a malpractice mitigation standpoint and have greater leverage with payers for appropriate reimbursement for their professional expertise.”

For more information: American Roentgen Ray Society (ARRS)

Related Content

Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology services, announced a number of steps it is taking as part of its aggressive transformational activity to position the company for long-term, sustainable growth
News | Radiology Business | June 05, 2020
June 5, 2020 — Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology
Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed this year by the American Society of Radiologic Technologists. Researchers noted, however, the survey data was collected before the COVID-19 pandemic began affecting the surveyed clinical settings.

Getty Images

News | Radiation Therapy | June 05, 2020
June 5, 2020 — Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration, discussed The COVID-19 Pandemic — Finding Solutions, Applying Lessons Learned, on June 1

Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — The following speech was delivere
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p
The opportunity to converge the silos of data into a cross-functional analysis can provide immense value during the COVID-19 outbreak and in the future

Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Jeff Vachon
In the midst of the coronavirus pandemic normal
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
Off-site imaging companies are playing a key role in the fight against COVID-19
Feature | Coronavirus (COVID-19) | May 26, 2020 | By Sean Zahniser
After the worst of the COVID-19 pandemic has pas